PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP)
CUSIP: 69353Y103
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 53,185,766
- Total 13F shares
- 51,696,984
- Share change
- +246,162
- Total reported value
- $323,689,509
- Put/Call ratio
- 17%
- Price per share
- $6.26
- Number of holders
- 104
- Value change
- +$3,281,155
- Number of buys
- 58
- Number of sells
- 53
Quarterly Holders Quick Answers
What is CUSIP 69353Y103?
CUSIP 69353Y103 identifies PMVP - PMV Pharmaceuticals, Inc. - COMMON STOCK in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 69353Y103:
Top shareholders of PMVP - PMV Pharmaceuticals, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
12%
|
6,563,077
|
$31,305,877 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
7.6%
|
4,030,169
|
$19,223,905 | — | 31 Mar 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
7.5%
|
4,002,874
|
$19,094,000 | — | 31 Mar 2023 | |
| Boxer Capital, LLC |
13F
|
Company |
5.9%
|
3,163,795
|
$15,091,000 | — | 31 Mar 2023 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
5.8%
|
3,060,000
|
$14,596,200 | — | 31 Mar 2023 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
5.6%
|
2,999,098
|
$14,305,697 | — | 31 Mar 2023 | |
| Euclidean Capital LLC |
13F
3/4/5
|
Company · 10%+ Owner |
4.4%
|
2,336,909
|
$11,147,056 | — | 31 Mar 2023 | |
| Verition Fund Management LLC |
13F
|
Company |
4%
|
2,147,351
|
$10,242,864 | — | 31 Mar 2023 | |
| INTERWEST PARTNERS X LP |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,502,480
|
$10,040,531 | — | 13 Jul 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.7%
|
1,963,420
|
$9,365,513 | — | 31 Mar 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
3.3%
|
1,780,104
|
$8,491,096 | — | 31 Mar 2023 | |
| INTERWEST VENTURE MANAGEMENT CO |
13F
|
Company |
3%
|
1,614,911
|
$7,703,125 | — | 31 Mar 2023 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.6%
|
1,381,329
|
$6,588,940 | — | 31 Mar 2023 | |
| OUP Management Co., LLC |
13F
|
Company |
1.9%
|
989,232
|
$4,718,637 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.8%
|
931,698
|
$4,444,199 | — | 31 Mar 2023 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
1.7%
|
917,885
|
$4,378,313 | — | 31 Mar 2023 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
1.7%
|
899,561
|
$4,290,906 | — | 31 Mar 2023 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.6%
|
870,054
|
$4,150,158 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
1.5%
|
775,000
|
$3,696,750 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
666,111
|
$3,177,349 | — | 31 Mar 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.2%
|
653,631
|
$3,117,820 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
1.2%
|
630,259
|
$3,006,335 | — | 31 Mar 2023 | |
| PERSONAL CFO SOLUTIONS, LLC |
13F
|
Company |
1%
|
550,342
|
$2,625,131 | — | 31 Mar 2023 | |
| Nextech Invest Ltd. |
13F
|
Company |
0.98%
|
521,284
|
$2,486,525 | — | 31 Mar 2023 | |
| Thilo Schroeder |
3/4/5
|
Director |
—
class O/S missing
|
1,101,283
|
$2,455,861 | — | 06 Oct 2021 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.94%
|
498,263
|
$2,376,715 | — | 31 Mar 2023 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.79%
|
420,824
|
$2,007,330 | — | 31 Mar 2023 | |
| PFM Health Sciences, LP |
13F
|
Company |
0.79%
|
418,027
|
$1,993,989 | — | 31 Mar 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.77%
|
407,312
|
$1,942,892 | — | 31 Mar 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.64%
|
342,152
|
$1,632,000 | — | 31 Mar 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.64%
|
340,983
|
$1,626,489 | — | 31 Mar 2023 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.61%
|
322,024
|
$1,536,054 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.58%
|
308,506
|
$1,471,574 | — | 31 Mar 2023 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.55%
|
292,652
|
$1,395,000 | — | 31 Mar 2023 | |
| Ergoteles LLC |
13F
|
Company |
0.48%
|
257,805
|
$1,229,730 | — | 31 Mar 2023 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.48%
|
256,563
|
$1,223,806 | — | 31 Mar 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.48%
|
255,922
|
$1,220,747 | — | 31 Mar 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.48%
|
253,474
|
$1,209,071 | — | 31 Mar 2023 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.47%
|
250,469
|
$1,194,737 | — | 31 Mar 2023 | |
| Vontobel Holding Ltd. |
13F
|
Company |
0.47%
|
250,469
|
$1,194,737 | — | 31 Mar 2023 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.47%
|
249,588
|
$1,190,535 | — | 31 Mar 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.44%
|
235,447
|
$1,123,082 | — | 31 Mar 2023 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.35%
|
187,800
|
$895,806 | — | 31 Mar 2023 | |
| Woodline Partners LP |
13F
|
Company |
0.33%
|
175,888
|
$838,986 | — | 31 Mar 2023 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.29%
|
156,058
|
$744,397 | — | 31 Mar 2023 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.29%
|
154,471
|
$736,827 | — | 31 Mar 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.26%
|
136,950
|
$653,252 | — | 31 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.23%
|
122,520
|
$584,420 | — | 31 Mar 2023 | |
| NEW YORK LIFE INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.18%
|
93,363
|
$445,342 | — | 31 Mar 2023 | |
| UBS Group AG |
13F
|
Company |
0.17%
|
89,644
|
$427,601 | — | 31 Mar 2023 |
Institutional Holders of PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP) as of Q2 2023
As of 30 Jun 2023,
PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP) was held by
104 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
51,696,984 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, BlackRock Inc., JPMORGAN CHASE & CO, Boxer Capital, LLC, Avoro Capital Advisors LLC, RTW INVESTMENTS, LP, Euclidean Capital LLC, Verition Fund Management LLC, CITADEL ADVISORS LLC, and VANGUARD GROUP INC.
This page lists
104
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
111
Q2 2023 holders
104
Holder diff
-7
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.